Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Advocates often stress the possibility for substantial therapeutic outcomes, especially in conditions where conventional therapies have proven inadequate. However, this is to assess the significant financial burden associated with CPI stem cell therapy